Defence Therapeutics Inc. Cash Flow-to-Debt Ratio
Defence Therapeutics Inc. cash flow-to-debt ratio. Defence Therapeutics Inc. (DTC) has a Cash Flow-to-Debt Ratio of -0.54x as of December 2025, meaning its operating cash flow of €-1.40 Million could theoretically repay -1% of its total liabilities (€2.59 Million) in one year. See DTC financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Defence Therapeutics Inc. (2020–2024)
Cash flow-to-debt ratio of Defence Therapeutics Inc. from 2020 to 2024. Historical debt coverage capacity for Defence Therapeutics Inc. across 5 annual periods. Check DTC capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Defence Therapeutics Inc. Cash Flow-to-Debt Ratio by Year (2020–2024)
Defence Therapeutics Inc. cash flow-to-debt ratio by year from 2020 to 2024. Year-by-year debt coverage analysis for Defence Therapeutics Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of Defence Therapeutics Inc..
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.06x | €-4.29 Million | €4.06 Million | ▲ +72.9% |
| 2023 | -3.89x | €-7.66 Million | €1.97 Million | ▲ +28.7% |
| 2022 | -5.46x | €-6.04 Million | €1.11 Million | ▲ +70.9% |
| 2021 | -18.73x | €-2.29 Million | €122.26K | ▼ -581.7% |
| 2020 | -2.75x | €-132.83K | €48.35K | — |